Wal-Mart stirred up a maelstrom of controversy when it launched its $4 generic drug prescription program in September.
This initiative, which is now national, caused many supermarkets and other mass merchants like Target, to respond with offers that matched and, in some cases, exceeded, Wal-Mart. The major drug chains have so far elected to stay on the sidelines.
Answering whether such pricing is good, bad or indifferent is beyond the scope of this column. What can be said is